Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prostate-specific membrane antigen.
Fair WR, Israeli RS, Heston WD. Fair WR, et al. Among authors: israeli rs. Prostate. 1997 Jul 1;32(2):140-8. doi: 10.1002/(sici)1097-0045(19970701)32:2<140::aid-pros9>3.0.co;2-q. Prostate. 1997. PMID: 9215402 Review.
Can prostate-specific antigen reverse transcriptase-polymerase chain reaction be used as a prospective test to diagnose prostate cancer?
Goldman HB, Israeli RS, Lu Y, Lerner JL, Hollabaugh RS, Steiner MS. Goldman HB, et al. Among authors: israeli rs. World J Urol. 1997;15(4):257-61. doi: 10.1007/BF01367664. World J Urol. 1997. PMID: 9280055 Clinical Trial.
Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.
Israeli RS, Miller WH Jr, Su SL, Samadi DS, Powell CT, Heston WD, Wise GJ, Fair WR. Israeli RS, et al. J Urol. 1995 Mar;153(3 Pt 1):573-7. doi: 10.1016/s0022-5347(01)67651-1. J Urol. 1995. PMID: 7532229 Clinical Trial.
Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.
Rinker-Schaeffer CW, Hawkins AL, Su SL, Israeli RS, Griffin CA, Isaacs JT, Heston WD. Rinker-Schaeffer CW, et al. Among authors: israeli rs. Genomics. 1995 Nov 1;30(1):105-8. doi: 10.1006/geno.1995.0019. Genomics. 1995. PMID: 8595888
Prostate-specific membrane antigen and other prostatic tumor markers on the horizon.
Israeli RS, Grob M, Fair WR. Israeli RS, et al. Urol Clin North Am. 1997 May;24(2):439-50. doi: 10.1016/s0094-0143(05)70391-8. Urol Clin North Am. 1997. PMID: 9126242 Review.
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
Israeli RS, Powell CT, Fair WR, Heston WD. Israeli RS, et al. Cancer Res. 1993 Jan 15;53(2):227-30. Cancer Res. 1993. PMID: 8417812
Reversal by transferrin of growth-inhibitory effect of suramin on hormone-refractory human prostate cancer cells.
Donat SM, Powell CT, Israeli RS, Fair WR, Heston WD. Donat SM, et al. Among authors: israeli rs. J Natl Cancer Inst. 1995 Jan 4;87(1):41-6. doi: 10.1093/jnci/87.1.41. J Natl Cancer Inst. 1995. PMID: 7666462
Expression of the prostate-specific membrane antigen.
Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD. Israeli RS, et al. Cancer Res. 1994 Apr 1;54(7):1807-11. Cancer Res. 1994. PMID: 7511053
Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, et al. Israeli RS, et al. Cancer Res. 1994 Dec 15;54(24):6306-10. Cancer Res. 1994. PMID: 7527294
Effect of prostate biopsy on the results of the PSA RT-PCR test.
Goldman HB, Israeli RS, Lerner JL, Hollabaugh RS Jr, Steiner MS. Goldman HB, et al. Among authors: israeli rs. Urology. 1998 Dec;52(6):1073-8. doi: 10.1016/s0090-4295(98)00358-6. Urology. 1998. PMID: 9836557 Clinical Trial.
15 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback